Sage Therapeutics, Inc.

Historical 13F Holders

Symbol
SAGE
CUSIP
78667J108
All holders as of
Q2 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q2 207 51.9 M $473 M
2025 Q1 208 51.8 M $412 M
2024 Q4 185 51.2 M $278 M
2024 Q3 189 51.6 M $375 M
2024 Q2 208 56.1 M $609 M
2024 Q1 220 62.2 M $1.17 B
2023 Q4 222 59.1 M $1.28 B
2023 Q3 216 59.1 M $1.22 B
2023 Q2 249 54.9 M $2.58 B
2023 Q1 231 53.2 M $2.23 B
2022 Q4 227 54.4 M $2.55 B
2022 Q3 221 52.4 M $2.05 B
2022 Q2 226 51.1 M $1.65 B
2022 Q1 234 50.7 M $1.68 B
2021 Q4 247 50.4 M $2.14 B
2021 Q3 245 49.1 M $2.17 B
2021 Q2 286 50.7 M $2.88 B
2021 Q1 291 53.1 M $3.97 B
2020 Q4 275 54.2 M $4.69 B
2020 Q3 257 53.7 M $3.28 B
2020 Q2 246 54.3 M $2.26 B
2020 Q1 255 56.3 M $1.62 B
2019 Q4 308 56.6 M $4.09 B
2019 Q3 323 59.0 M $8.30 B
2019 Q2 317 58.2 M $10.7 B
2019 Q1 301 56.9 M $9.04 B
2018 Q4 290 50.2 M $4.81 B
2018 Q3 309 50.4 M $7.12 B
2018 Q2 294 48.8 M $7.64 B
2018 Q1 272 47.9 M $7.70 B
2017 Q4 257 44.1 M $7.26 B
2017 Q3 207 39.4 M $2.46 B
2017 Q2 223 38.4 M $3.06 B
2017 Q1 222 37.9 M $2.69 B
2016 Q4 183 36.9 M $1.88 B
2016 Q3 167 37.8 M $1.74 B
2016 Q2 169 30.2 M $920 M
2016 Q1 150 29.7 M $953 M
2015 Q4 145 23.6 M $1.38 B
2015 Q3 143 28.0 M $1.20 B
2015 Q2 130 26.4 M $1.93 B
2015 Q1 93 21.5 M $1.08 B
2014 Q4 74 20.3 M $736 M
2014 Q3 53 18.9 M $596 M